Substitute House Bill No. 193 - Summary

• Replaces term "naloxone" with "overdose reversal drug" throughout Ohio Revised Code to allow for future FDA-approved alternatives beyond naloxone for treating opioid overdoses.

• Modifies electronic prescription requirements for Schedule II controlled substances, allowing written prescriptions in additional circumstances including temporary technical failures, nursing home/hospice patients, and state agency pharmacist dispensing.

• Establishes a two-year pilot program for dispensing Schedule II controlled substances in lockable or tamper-evident containers to reduce drug diversion, with Department of Mental Health and Addiction Services reimbursing participating pharmacies.

• Clarifies out-of-state physician consultation rules by removing the requirement that the Ohio physician be "responsible for examination, diagnosis, and treatment," replacing it with requiring an "established physician-patient relationship."

• Expands pediatric respite care program definitions and licensing requirements to accommodate both facility-based and home-like settings serving children under 27 with life-threatening conditions.